Athyrium Capital Management, LP — Q4 2018 13F Holdings

Name: Athyrium Capital Management, LP — 13F Holdings, Q4 2018
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001728001

Total reported value

$8.7B

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	Stock-Other	85.94%	—	-11.70%
2	PTCT 3 08-15-22	Ptc Therapeutics INC	Stock-Healthcare	7.78%	—	-65.03%
3	✓	Kala Bio INC Com New	Stock-Other	6.28%	—	—

Position changes disclosed by Athyrium Capital Management, LP for the quarter ending Q4 2018, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	+8.6%	-11.70%	Trim
2	PTCT 3 08-15-22	Ptc Therapeutics INC	-13.5%	-65.03%	Trim
3	✓	Kala Bio INC Com New	—	NEW	New buy
4	HQ8F	Apollo Endosurgery INC	—	EXIT	Sold out